Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | TRAK2 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | HMBS | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | CCR6 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | TBXA2R | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | CISH | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | RAB37 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-09 |
mRNA | ASH2L | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |